Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 184

    1.

    Mycophenolate Mofetil Versus Azathioprine in Organ Transplantation.

    Cravedi P, Perna A, Ruggenenti P, Remuzzi G.

    Am J Transplant. 2009 Oct 21. [Epub ahead of print] No abstract available. PMID: 19845579 [PubMed - as supplied by publisher]Related articles

    2.

    Impact of The PPAR-{gamma}2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 Diabetes: evidence from Benedict.

    De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; on behalf of the BENEDICT Study Group.

    Diabetes. 2009 Aug 31. [Epub ahead of print]PMID: 19720797 [PubMed - as supplied by publisher]Related articles

    3.

    Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.

    Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ.

    Pharmacogenet Genomics. 2009 Sep;19(9):695-703.PMID: 19696696 [PubMed - indexed for MEDLINE]Related articles

    4.

    Proteinuria: Is the ONTARGET renal substudy actually off target?

    Ruggenenti P, Remuzzi G.

    Nat Rev Nephrol. 2009 Aug;5(8):436-7. No abstract available. PMID: 19639016 [PubMed - indexed for MEDLINE]Related articles

    5.

    Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy.

    Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, Orisio S, Remuzzi G.

    Hypertension. 2009 Sep;54(3):567-74. Epub 2009 Jul 20.PMID: 19620516 [PubMed - indexed for MEDLINE]Related articles

    6.

    Proteinuria: Increased angiotensin-receptor blocking is not the first option.

    Ruggenenti P, Cravedi P, Remuzzi G.

    Nat Rev Nephrol. 2009 Jul;5(7):367-8.PMID: 19556990 [PubMed - indexed for MEDLINE]Related articles

    7.

    ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.

    Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N, Gotti E, Sandrini S, Salvadori M, Segoloni G, Rigotti P, Donati D, Perico N, Remuzzi G; Mycophenolate Steroids Sparing (MYSS) Genetics Study Group.

    J Am Soc Nephrol. 2009 Jun;20(6):1404-15. Epub 2009 May 21.PMID: 19470683 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sirolimus to replace calcineurin inhibitors? Too early yet.

    Cravedi P, Ruggenenti P, Remuzzi G.

    Lancet. 2009 Apr 11;373(9671):1235-6. Review. No abstract available. PMID: 19362662 [PubMed - indexed for MEDLINE]Related articles

    9.

    Outcome of renal transplantation from very old donors.

    Rigotti P, Ekser B, Furian L, Baldan N, Valente ML, Boschiero L, Motterlini N, Perna A, Remuzzi G, Ruggenenti P.

    N Engl J Med. 2009 Apr 2;360(14):1464-5. No abstract available. PMID: 19339731 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

    Cravedi P, Ruggenenti P, Remuzzi G.

    Curr Hypertens Rep. 2009 Apr;11(2):118-24.PMID: 19278601 [PubMed]Related articles

    11.

    Developing regulatory-compliant electronic case report forms for clinical trials: experience with the demand trial.

    Ene-Iordache B, Carminati S, Antiga L, Rubis N, Ruggenenti P, Remuzzi G, Remuzzi A.

    J Am Med Inform Assoc. 2009 May-Jun;16(3):404-8. Epub 2009 Mar 4.PMID: 19261946 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Thrice-weekly in-center nocturnal hemodialysis: an effective strategy to optimize chronic dialysis therapy.

    Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G.

    Int J Artif Organs. 2009 Jan;32(1):12-9.PMID: 19241359 [PubMed - indexed for MEDLINE]Related articles

    13.

    Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.

    Saland JM, Ruggenenti P, Remuzzi G; Consensus Study Group.

    J Am Soc Nephrol. 2009 May;20(5):940-9. Epub 2008 Dec 17. Review.PMID: 19092117 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rituximab for membranous nephropathy and immune disease: less might be enough.

    Ruggenenti P, Cravedi P, Remuzzi G.

    Nat Clin Pract Nephrol. 2009 Feb;5(2):76-7. Epub 2008 Dec 2. Review. No abstract available. PMID: 19048001 [PubMed - indexed for MEDLINE]Related articles

    15.

    Renal hemodynamics and renoprotection.

    Loriga G, Vidili G, Ruggenenti P, Faedda R, Sanna M, Satta AE.

    Nephron Clin Pract. 2008;110(4):c213-9. Epub 2008 Oct 31.PMID: 18974652 [PubMed - indexed for MEDLINE]Related articles

    16.

    Islet transplantation: need for a time-out?

    Cravedi P, Mannon RB, Ruggenenti P, Remuzzi A, Remuzzi G.

    Nat Clin Pract Nephrol. 2008 Dec;4(12):660-1. Epub 2008 Sep 23. No abstract available. PMID: 18813231 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

    Ruggenenti P, Cravedi P, Sghirlanzoni MC, Gagliardini E, Conti S, Gaspari F, Marchetti G, Abbate M, Remuzzi G.

    Clin J Am Soc Nephrol. 2008 Nov;3(6):1652-9. Epub 2008 Aug 6.PMID: 18684896 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.

    Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G.

    Clin J Am Soc Nephrol. 2008 Sep;3(5):1511-25. Epub 2008 Jun 11. Review.PMID: 18550651 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).

    Ruggenenti P, Iliev I, Costa GM, Parvanova A, Perna A, Giuliano GA, Motterlini N, Ene-Iordache B, Remuzzi G; Bergamo Nephrologic Diabetes Complications Trial Study Group.

    Diabetes Care. 2008 Aug;31(8):1629-34. Epub 2008 Apr 28.PMID: 18443191 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Role of remission clinics in the longitudinal treatment of CKD.

    Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G.

    J Am Soc Nephrol. 2008 Jun;19(6):1213-24. Epub 2008 Mar 19.PMID: 18354029 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Decision time for pancreatic islet-cell transplantation.

    Ruggenenti P, Remuzzi A, Remuzzi G.

    Lancet. 2008 Mar 15;371(9616):883-4. No abstract available. PMID: 18342671 [PubMed - indexed for MEDLINE]Related articles

    22.

    Mechanisms of progression of chronic renal disease.

    Pisoni R, Aros C, Ruggenenti P, Remuzzi G.

    Saudi J Kidney Dis Transpl. 2002 Jul-Sep;13(3):250-6.PMID: 18209421 [PubMed - in process]Related articlesFree article

    23.

    Intensified inhibition of renin-angiotensin system: a way to improve renal protection?

    Cravedi P, Ruggenenti P, Remuzzi G.

    Curr Hypertens Rep. 2007 Nov;9(5):430-6. Review.PMID: 18177592 [PubMed - indexed for MEDLINE]Related articles

    24.

    Latest treatment strategies for membranous nephropathy.

    Ruggenenti P, Cravedi P, Remuzzi G.

    Expert Opin Pharmacother. 2007 Dec;8(18):3159-71. Review.PMID: 18035960 [PubMed - indexed for MEDLINE]Related articles

    25.

    Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

    Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M, Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G.

    Transplantation. 2007 Oct 27;84(8):956-64.PMID: 17989600 [PubMed - indexed for MEDLINE]Related articles

    26.

    Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.

    Sharma SK, Ruggenenti P, Remuzzi G.

    Vasc Health Risk Manag. 2007;3(4):453-65. Review.PMID: 17969376 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Kidney failure stabilizes after a two-decade increase: impact on global (renal and cardiovascular) health.

    Ruggenenti P, Remuzzi G.

    Clin J Am Soc Nephrol. 2007 Jan;2(1):146-50. Epub 2006 Nov 29. No abstract available. PMID: 17699399 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Rituximab for idiopathic membranous nephropathy: who can benefit?

    Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, Remuzzi G.

    Clin J Am Soc Nephrol. 2006 Jul;1(4):738-48. Epub 2006 Jun 14.PMID: 17699281 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.

    Ruggenenti P, Codreanu I, Cravedi P, Perna A, Gotti E, Remuzzi G.

    Clin J Am Soc Nephrol. 2006 May;1(3):546-54. Epub 2006 Mar 1.PMID: 17699258 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.

    Cravedi P, Ruggenenti P, Sghirlanzoni MC, Remuzzi G.

    Clin J Am Soc Nephrol. 2007 Sep;2(5):932-7. Epub 2007 Aug 16.PMID: 17702725 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.

    Ruilope L, Kjeldsen SE, de la Sierra A, Mancia G, Ruggenenti P, Stergiou GS, Bakris GL, Giles TD.

    Blood Press. 2007;16(2):72-9. Review.PMID: 17612904 [PubMed - indexed for MEDLINE]Related articles

    32.

    Kidney failure stabilizes after an increase over 2 decades.

    Cravedi P, Ruggenenti P, Remuzzi G.

    J Ren Care. 2007 Jul-Sep;33(3):100-4. Review.PMID: 19160879 [PubMed - indexed for MEDLINE]Related articles

    33.

    Misleading meta-analysis: a need to look beyond the headlines.

    Chaturvedi N, Bilous R, Hardy R, Remuzzi G, Ruggenenti P, Viberti GC.

    Diabet Med. 2007 Jun;24(6):587-91. Epub 2007 May 8. No abstract available. PMID: 17490423 [PubMed - indexed for MEDLINE]Related articles

    34.

    Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

    Remuzzi G, Cravedi P, Costantini M, Lesti M, Ganeva M, Gherardi G, Ene-Iordache B, Gotti E, Donati D, Salvadori M, Sandrini S, Segoloni G, Federico S, Rigotti P, Sparacino V, Ruggenenti P.

    J Am Soc Nephrol. 2007 Jun;18(6):1973-85. Epub 2007 Apr 25.PMID: 17460145 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Does remission of renal disease associated with antihypertensive treatment exist?

    Cravedi P, Ruggenenti P, Remuzzi G.

    Curr Hypertens Rep. 2007 Apr;9(2):160-5. Review.PMID: 17442229 [PubMed - indexed for MEDLINE]Related articles

    36.

    The Bergamo Kidney Transplant Program.

    Perico N, Cravedi P, Ruggenenti P, Gotti E, Rota G, Locatelli G, Gambara V, Perna A, Rota S, Remuzzi G.

    Clin Transpl. 2005:85-100.PMID: 17424727 [PubMed - indexed for MEDLINE]Related articles

    37.

    How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?

    Ruggenenti P, Remuzzi G.

    Nat Clin Pract Nephrol. 2007 Mar;3(3):126-7. Epub 2007 Jan 30. No abstract available. PMID: 17262073 [PubMed]Related articles

    38.

    Is mycophenolate mofetil better than azathioprine in organ transplantation?

    Ruggenenti P, Remuzzi G.

    Transplantation. 2006 Nov 15;82(9):1242-3. No abstract available. PMID: 17102781 [PubMed - indexed for MEDLINE]Related articles

    39.

    Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study.

    Tessari G, Naldi L, Boschiero L, Cordiano C, Piaserico S, Fortina AB, Cerimele D, La Parola IL, Capuano M, Gotti E, Ruggenenti P, Sassi F, Remuzzi G, Girolomoni G.

    Eur J Dermatol. 2006 Sep-Oct;16(5):553-7.PMID: 17101478 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Preventing microalbuminuria in patients with type 2 diabetes.

    Jermendy G, Ruggenenti P.

    Diabetes Metab Res Rev. 2007 Feb;23(2):100-10. Review.PMID: 17094161 [PubMed - indexed for MEDLINE]Related articles

    41.

    Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.

    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G; BENEDICT Study Group.

    J Am Soc Nephrol. 2006 Dec;17(12):3472-81. Epub 2006 Nov 2.PMID: 17082240 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Ways to boost kidney transplant viability: a real need for the best use of older donors.

    Ruggenenti P, Perico N, Remuzzi G.

    Am J Transplant. 2006 Nov;6(11):2543-7. Epub 2006 Sep 4. Review.PMID: 16952296 [PubMed - indexed for MEDLINE]Related articles

    43.

    What blood-pressure level provides greatest renoprotection in patients with diabetic nephropathy and hypertension?

    Ruggenenti P, Remuzzi G.

    Nat Clin Pract Nephrol. 2006 May;2(5):250-1. No abstract available. PMID: 16932436 [PubMed - indexed for MEDLINE]Related articles

    44.

    Overview of randomised trials of ACE inhibitors.

    Remuzzi G, Ruggenenti P.

    Lancet. 2006 Aug 12;368(9535):555-6. Review. No abstract available. PMID: 16905000 [PubMed - indexed for MEDLINE]Related articles

    45.

    Time to abandon microalbuminuria?

    Ruggenenti P, Remuzzi G.

    Kidney Int. 2006 Oct;70(7):1214-22. Epub 2006 Jul 26. Review.PMID: 16871239 [PubMed - indexed for MEDLINE]Related articles

    46.

    Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion.

    Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, Remuzzi G, Ruggenenti P.

    Diabetes. 2006 May;55(5):1456-62.PMID: 16644705 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.

    Remuzzi G, Macia M, Ruggenenti P.

    J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S90-7. Review.PMID: 16565256 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Long-term outcome of renal transplantation from older donors.

    Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G, Rigotti P, Baldan N, Beatini M, Valente U, Scalamogna M, Ruggenenti P; Dual Kidney Transplant Group.

    N Engl J Med. 2006 Jan 26;354(4):343-52.PMID: 16436766 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    [Hemolytic uremic syndrome]

    Rota S, Cravedi P, Remuzzi G, Ruggenenti P.

    G Ital Nefrol. 2005 Nov-Dec;22 Suppl 33:S57-64. Review. Italian. PMID: 16419008 [PubMed - indexed for MEDLINE]Related articles

    50.

    The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

    Remuzzi G, Perico N, Macia M, Ruggenenti P.

    Kidney Int Suppl. 2005 Dec;(99):S57-65. Review.PMID: 16336578 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...